- Home
- ONCY vs STRO Comparison
ONCY vs STRO Comparison
Compare ONCY & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- STRO
- Stock Information
- Founded
- ONCY 1998
- STRO 2003
- Country
- ONCY Canada
- STRO United States
- Employees
- ONCY N/A
- STRO N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONCY Health Care
- STRO Health Care
- Exchange
- ONCY Nasdaq
- STRO Nasdaq
- Market Cap
- ONCY 89.7M
- STRO 77.7M
- IPO Year
- ONCY 1999
- STRO 2018
- Fundamental
- Price
- ONCY $1.05
- STRO $0.89
- Analyst Decision
- ONCY Strong Buy
- STRO Hold
- Analyst Count
- ONCY 4
- STRO 7
- Target Price
- ONCY $4.33
- STRO $3.97
- AVG Volume (30 Days)
- ONCY 1.5M
- STRO 1.1M
- Earning Date
- ONCY 08-08-2025
- STRO 08-12-2025
- Dividend Yield
- ONCY N/A
- STRO N/A
- EPS Growth
- ONCY N/A
- STRO N/A
- EPS
- ONCY N/A
- STRO N/A
- Revenue
- ONCY N/A
- STRO $66,434,000.00
- Revenue This Year
- ONCY N/A
- STRO N/A
- Revenue Next Year
- ONCY N/A
- STRO N/A
- P/E Ratio
- ONCY N/A
- STRO N/A
- Revenue Growth
- ONCY N/A
- STRO N/A
- 52 Week Low
- ONCY $0.33
- STRO $0.52
- 52 Week High
- ONCY $1.53
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- ONCY 53.00
- STRO 59.85
- Support Level
- ONCY $1.18
- STRO $0.74
- Resistance Level
- ONCY $1.35
- STRO $1.01
- Average True Range (ATR)
- ONCY 0.13
- STRO 0.06
- MACD
- ONCY -0.03
- STRO 0.02
- Stochastic Oscillator
- ONCY 14.29
- STRO 54.52
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.